Survivor Story: Lutetium PSMA Therapy in Australia
- folarinolawale3415
- Sep 21
- 1 min read
Date: 18 August 2025
Source: Courier-Mail
82-year-old Garry Carter outlived a terminal prostate cancer diagnosis thanks to Lutetium
PSMA therapy. His story shows how targeted treatments can extend survival and highlights
the importance of early access and screening.
Comments